Business Context and Reporting Period
Company: LeMaitre Vascular, Inc. (LMAT)
Filing Type: Form 8-K (Current Report)
Date of Report: February 27, 2024
Reporting Period: Preliminary financial and operational results for the quarter ended December 31, 2023.
Key Financial Metrics
This Form 8-K serves as a notification of a press release (Exhibit 99.1) containing preliminary results. The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release for these figures.
Material Changes
The filing text does not disclose specific material changes or comparative data versus the prior period. It only confirms the issuance of preliminary results for the quarter ended December 31, 2023.
Guidance, Outlook, and Risks
Forward-Looking Statements: The report contains forward-looking statements based on management's current preliminary expectations. These are subject to risks and uncertainties that could cause actual results to differ materially.
Risk Factors: Specific risks are referenced in the Company's most recent Annual Report on Form 10-K and subsequent filings.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is furnished, not "filed," for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, earnings, and cash flow figures for Q4 2023.
- Verify the "Risk Factors" section in the most recent Form 10-K for detailed uncertainties affecting forward-looking statements.
- Confirm whether the preliminary results in the press release have been updated in subsequent filings.
- Note that the data in this 8-K is preliminary and subject to change.